Vericel Corporation (VCEL) Stock Analysis

Free AI-powered analysis and research for Vericel Corporation stock

Sector: Healthcare

Analyze Vericel Corporation (VCEL) Stock

Vericel Corporation (VCEL) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into VCEL stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Vericel Corporation stock.

📰 Latest Update

MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

Thu, April 2, 2026 at 7:26 PM UTC 4 min read

Vericel Corporation (VCEL) has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA) for its NexoBrid® product, valued at up to $197 million. This contract signifies a strong endorsement of NexoBrid's potential in the market and could enhance Vericel's revenue streams. Investors may view this development as a positive indicator of the company's growth prospects and its ability to secure significant government contracts.

Read full article →

Why Analyze Vericel Corporation (VCEL) with StockIQ?

• ✅ Free AI-powered analysis of Vericel Corporation (VCEL) stock
• ✅ Real-time technical indicators for Vericel Corporation stock
• ✅ Comprehensive risk assessment for VCEL
• ✅ No credit card required

People also watch